Licensure
Current licensure in good standing, including non-resident licensure in the states where your patients actually live.
Physician-prescribed, patient-specific compounding through 503a pharmacies MedReps has evaluated and credentialed first — so what we hand you is a standard, not just a phone number.
A 503a pharmacy compounds a preparation for one identified patient against one prescription from one prescriber. It is not manufacturing, and it is not interchangeable with an off-the-shelf drug.
That model only works if the pharmacy behind it is sound. So MedReps does not partner with a single pharmacy and call it a solution — we evaluate and credential every pharmacy in the network, and we keep evaluating them.
The result for your practice: the formulary depth and the 50-state reach of a network, with the quality question already answered before the introduction is ever made.
Current licensure in good standing, including non-resident licensure in the states where your patients actually live.
Inspection and regulatory history reviewed, with ongoing monitoring rather than a one-time check at onboarding.
Demonstrated practice against USP compounding standards for non-sterile and sterile preparations, including facility and personnel controls.
Documented API sourcing, potency and sterility testing appropriate to the preparation, and defensible beyond-use dating.
Turnaround times, direct-to-provider and direct-to-patient shipping, and cold-chain handling where the preparation requires it.
Willingness to work with a provider's protocols and to answer a clinical question in hours, not days.
One of the most extensive 503a formularies available in the country, paired with a 50-state licensed footprint. Fewer bottlenecks, more protocols, and no partner in the network we have not evaluated ourselves.
A state-licensed pharmacy that compounds preparations for an individually identified patient against a valid prescription. It is patient-specific by definition, which is what separates it from a 503b outsourcing facility that compounds in batches for office stock.
We review licensure and non-resident licensure, inspection and regulatory history, practice against USP compounding standards, API sourcing and testing, beyond-use dating, fulfillment reliability, and clinical responsiveness. Pharmacies stay under review after onboarding, not just before it.
Because a single relationship becomes a single point of failure — for licensure, for formulary gaps, for turnaround, and for you. A vetted network lets us route a prescription to the pharmacy best positioned to fill it and keeps our standard, not one partner's capacity, as the constraint.
Yes. You write a patient-specific prescription and the pharmacy compounds and dispenses against it. MedReps does not prescribe, compound, or dispense.
No. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety or effectiveness. Prescribing them is a clinical judgment you make within applicable law.
It runs well past peptides — hormone replacement, men's and women's sexual health, a deep dermatology and topical book, weight management support, and a range of specialty preparations. Ask us for the current formulary and we will send it.
The network carries licensure across all 50 states. Specific preparations can still be limited by state law, so availability is confirmed per preparation and per state.
Tell us your specialty and the states you practice in, and we will send the formulary and make the introduction to the right pharmacy in the network.